1. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, Copeland JR, Dartigues JF, Jagger C, Martinez-Lage J, Soininen H, Hofman A (2000) Preva- lence of dementia and major subtypes in Europe: a col- laborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology 54:4–9
2. Mendez MF, Mendez MA, Martin R, Smyth KA, White- house PJ (1990) Complex visual disturbances in Alzheimer’s disease. Neurology 40:439–443
3. Holoryd S, Sphepherd ML (2001) Alzheimer’s disease: a review for the ophthalmologist. Surv Ophthalmol 45: 516–524
4. Sadun AA, Bassi CJ (1990) The visual system in Alzheimer’s disease. Res Publ Assoc Res Nerv Ment Dis 67:331–347
5. Katz B, Rimmer S (1989) Ophthalmologic manifestations of Alzheimer’s disease. Surv Ophthalmol 34:31–43
6. Pelak VS, Hall DA (2004) Neuro-ophthalmic manifestations of neurodegenerative disease. Ophthalmol Clin North Am 17:311–320
7. Fletcher WA (1994) Ophthalmological aspects of Alzheimer’s disease. Curr Opin Ophthalmol 5:38–44
8. Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL (2007) Retinal abnormalities in early Alzheimer’s disease. Invest Ophthalmol Vis Sci 48:2285–2289
9. Hinton DR, Sadun AA, Blanks JC, Miller CA (1986) Optic-nerve degeneration in Alzheimer’s disease. N Engl J Med 315:485–487
10. Danesh-Meyer HV, Birch H, Ku JY, Carroll S, Gamble G (2006) Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology 67:1852–1854
11. Syed AB, Armstrong RA, Smith CU (2005) A quantitative analysis of optic nerve axons in elderly control subjects and patients with Alzheimer’s disease. Folia Neuropathol 43:1–6
12. Frederikse PH, Garland D, Zigler JS Jr, Piatigorsky J (1996) Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mam- malian lenses, and Abeta has toxic effects on lens epithelial cells. J Biol Chem 271:10169–10174
13. Bruban J, Glotin AL, Dinet V, Chalour N, Sennlaub F, Jonet L, An N, Faussat AM, Mascarelli F (2009) Amyloid- beta(1–42) alters structure and function of retinal pig- mented epithelial cells. Aging Cell 8:162–177
14. Townes-Anderson E, Vogt BA (1989) Distribution of muscarinic acetylcholine receptors on processes of isolated retinal cells. J Comp Neurol 290:369–383
15. Katz B, Rimmer S, Iragui V, Katzman R (1989) Abnormal pattern electroretinogram in Alzheimer’s disease: evidence for retinal ganglion cell degeneration? Ann Neurol 26:221–225
16. Trick GL, Barris MC, Bickler-Bluth M (1989) Abnormal pattern electroretinogram in patients with senile dementia of the Alzheimer type. Ann Neurol 26:226–231
17. Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F (2001) Morphological and functional retinal impairment in Alzheimer’s disease patients. Clin Neurophysiol 112:1860–1867
18. Partanen J, Hartikainen P, K  ̈n  ̈nen M, Jousm  ̈ki V, Soi- nien H, Riekkinen P (1994) Prolonged latencies of pattern reversal visual evoked early potentials in Alzheimer disease. Alzheimer Dis Assoc Disord 8:250–258
19. Pollock VE, Schneider LS, Chui HC, Henderson V, Ze- mansky M, Sloane RB (1989) Visual evoked potentials in dementia: a meta-analysis and empirical study of Alzheimer’s disease patients. Biol Psychiatry 25:1003–1013
20. Grayson AS, Weiler EM, Sandman DE (1995) Visual evoked potentials in early Alzheimer’s dementia: an exploratory study. J Gen Psychol 122:113–129
21. Kergoat H, Kergoat MJ, Justino L, Chertkow H, Robillard A, Bergman H (2002) Visual retinocortical function in dementia of the Alzheimer’s type. Gerontology 48:197–203
22. Rizzo JF 3rd, Cronin-Golomb A, Growdon JH, Corkin S, Rosen TJ, Sandberg MA, Chiappa KH, Lessell S (1992) Retinocalcarine function in Alzheimer’s disease. A clinical and electrophysiological study. Arch Neurol 49:93–101
23. Strenn K, Dal-Bianco P, Weghaupt H, Koch G, Vass C, Gottlob I (1991) Pattern electroretinogram and luminance electroretinogram in Alzheimer’s disease. J Neural Transm Suppl 33:73–80
24. Iseri P, Altina  ̧ O  ̈ , Tokay T, Y uskel N (2006) Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuro-Ophthalmol 26:18–24
25. Philpot MP, Amin D, Levy R (1990) Visual evoked potentials in Alzheimer’s disease: correlation with age and severity. Electroencephalogr Clin Neurophysiol 77:323–329
26. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical Diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of the department of health and human ser- vices task force on Alzheimer’s disease. Neurology 34:939–944
27. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
28. Celesia GG, Kaufman D (1985) Pattern ERGs and visual evoked potentials in maculopathies and optic nerve diseases. Invest Ophthalmol Vis Sci 26:726–735
29. Celesia GG, Kaufman D, Cone SB (1986) Simultaneous recording of pattern electroretinography and visual evoked potentials in multiple sclerosis. A method to separate demyelination from axonal damage to the optic nerve. Arch Neurol 43:1247–1252
30. Bach M, Hawlina M, Holder GE, Marmor MF, Meigen T, Vaegan, Miyake Y (2000) Standard for pattern electroretinography. Doc Ophthalmol 101:11–18
31. Holder GE, Brigell MG, Hawlina M, Meigen T, Vaegan, Bach M (2007) ISCEV standard for clinical pattern elec- troretinography—2007 update. Doc Ophthalmol 114: 111–116
32. Odom JV, Bach M, Barber C, Brigell M, Marmor MF, Tormene AP, Holder GE, Vaegan (2004) Visual evoked potentials standard (2004). Doc Ophthalmol 108:115–123
33. Odom JV, Bach M, Brigell M, Holder GH, McCulloch DL, Tormene AP, Vaegan (2010) ISCEV standard for clinical Visual Evoked Potentials Standard (2009 update). Doc Ophthalmol 120:111–119
34. American Clinical Neurophysiology Society (2006) Guideline 5: guidelines for standard electrode position nomenclature. J Clin Neurophysiol 23:107–110
35. Holder GH (2006) The pattern electroretinogram. In: Heckenlively JR, Arden GB (eds) Principles and practice of clinical electrophysiology of vision, 2nd edn. MIT Press, Cambridge, pp 341–351
36. Viswanathan S, Frishman LJ, Robson JG (2000) The uni- form field and pattern ERG in macaques with experimental glaucoma: removal of spiking activity. Invest Ophthalmol Vis Sci 41:2797–2810
37. Holder GH (2006) Localizing lesions in the visual system. In: Heckenlively JR, Arden GB (eds) Principles and practice of clinical electrophysiology of vision, 2nd edn. MIT Press, Cambridge, pp 505–517
38. Eckstein MB, Spalton DJ, Holder G (1993) Visual loss from central serous retinopathy in systemic lupus erythe- matosus. Br J Ophthalmol 77:607–609
39. Lam BL (2005) Visual evoked potential. In: Lam BL (ed) Electrophysiology of vision. Clinical testing and applica- tions, 1st edn. Taylor&Francis Group, Boca Raton, pp 123–135
40. Bodis-Wollner I, Antal A (2006) Optic nerve and central nervous dysfunctions: Parkinson’s disease and multiple sclerosis. In: Heckenlively JR, Arden GB (eds) Principles and practice of clinical electrophysiology of vision, 2nd edn. MIT Press, Cambridge, pp 341–351
41. Parisi V, Pernini C, Guinetti C, Neuschuler R, Bucci MG (1997) Electrophysiological assessment of visual pathways in glaucoma. Eur J Ophthalmol 7:229–235
42. L  ̈ffler KU, Edward DP, Tso MO (1995) Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina. Invest Ophthalmol Vis Sci 36:24–31
43. Liu B, Rasool S, Yang Z, Glabe CG, Schreiber SS, Ge J, Tan Z (2009) Amyloid-peptide vaccinations reduce {beta}- amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer’s transgenic mice. Am J Pathol 175:2099–2110
44. Melo JB, Agostinho P, Oliveira CR (2002) Amyloid beta- peptide 25–35 reduces [3H]acetylcholine release in retinal neurons. Involvement of metabolic dysfunction. Amyloid 9:221–228
45. Aruoma OI, Jen SS, Watts HR, George J, Gentleman SM, Anderson PJ, Jen LS (2009) Acute and chronic effects of intravitreally injected beta-amyloid on the neurotransmitter system in the retina. Toxicology 256:92–100
46. Dimitrieva NA, Christianne ES, Kent TK (2007) Expres- sion of alpha 7 nicotinic acetylcholine receptors by bipolar, amacrine, and ganglion cells of the rabbit retina. J Histo- chem Cytochem 55:461–476